Baseline Neutrophil-To-Lymphocyte Ratio (NLR) and Derived NLR Could Predict Overall Survival in Patients With Advanced Melanoma Treated With Nivolumab
Journal for ImmunoTherapy of Cancer - United Kingdom
doi 10.1186/s40425-018-0383-1
Full Text
Open PDFAbstract
Available in full text
Date
July 16, 2018
Authors
Publisher
BMJ